These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 18694901)

  • 1. Sublingual buprenorphine for treatment of neonatal abstinence syndrome: a randomized trial.
    Kraft WK; Gibson E; Dysart K; Damle VS; Larusso JL; Greenspan JS; Moody DE; Kaltenbach K; Ehrlich ME
    Pediatrics; 2008 Sep; 122(3):e601-7. PubMed ID: 18694901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Revised dose schema of sublingual buprenorphine in the treatment of the neonatal opioid abstinence syndrome.
    Kraft WK; Dysart K; Greenspan JS; Gibson E; Kaltenbach K; Ehrlich ME
    Addiction; 2011 Mar; 106(3):574-80. PubMed ID: 20925688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Population Pharmacokinetic Model of Sublingual Buprenorphine in Neonatal Abstinence Syndrome.
    Ng CM; Dombrowsky E; Lin H; Erlich ME; Moody DE; Barrett JS; Kraft WK
    Pharmacotherapy; 2015 Jul; 35(7):670-80. PubMed ID: 26172282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Buprenorphine for the Treatment of the Neonatal Abstinence Syndrome.
    Kraft WK; Adeniyi-Jones SC; Chervoneva I; Greenspan JS; Abatemarco D; Kaltenbach K; Ehrlich ME
    N Engl J Med; 2017 Jun; 376(24):2341-2348. PubMed ID: 28468518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physiologically-Based Pharmacokinetic Modeling to Investigate the Effect of Maturation on Buprenorphine Pharmacokinetics in Newborns with Neonatal Opioid Withdrawal Syndrome.
    van Hoogdalem MW; Johnson TN; McPhail BT; Kamatkar S; Wexelblatt SL; Ward LP; Christians U; Akinbi HT; Vinks AA; Mizuno T
    Clin Pharmacol Ther; 2022 Feb; 111(2):496-508. PubMed ID: 34679189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extended-release versus oral buprenorphine as opioid maintenance treatment during pregnancy-maternal and neonatal outcomes.
    Kanervo M; Tupola S; Nikkola E; Rantakari K; Kahila H
    Eur J Obstet Gynecol Reprod Biol; 2024 Jun; 297():106-110. PubMed ID: 38608352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Buprenorphine in Neonatal Abstinence Syndrome.
    Kraft WK
    Clin Pharmacol Ther; 2018 Jan; 103(1):112-119. PubMed ID: 29105752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Salivary Therapeutic Monitoring of Buprenorphine in Neonates After Maternal Sublingual Dosing Guided by Physiologically Based Pharmacokinetic Modeling.
    Alsmadi MM
    Ther Drug Monit; 2024 Aug; 46(4):512-521. PubMed ID: 38366333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Buprenorphine Implants on Illicit Opioid Use Among Abstinent Adults With Opioid Dependence Treated With Sublingual Buprenorphine: A Randomized Clinical Trial.
    Rosenthal RN; Lofwall MR; Kim S; Chen M; Beebe KL; Vocci FJ;
    JAMA; 2016 Jul; 316(3):282-90. PubMed ID: 27434441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic Evaluation of Once-Weekly and Once-Monthly Buprenorphine Subcutaneous Injection Depots (CAM2038) Versus Intravenous and Sublingual Buprenorphine in Healthy Volunteers Under Naltrexone Blockade: An Open-Label Phase 1 Study.
    Albayaty M; Linden M; Olsson H; Johnsson M; Strandgården K; Tiberg F
    Adv Ther; 2017 Feb; 34(2):560-575. PubMed ID: 28070862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of Neonatal Abstinence Syndrome Treatment with Sublingual Buprenorphine versus Conventional Opioids.
    Hall ES; Rice WR; Folger AT; Wexelblatt SL
    Am J Perinatol; 2018 Mar; 35(4):405-412. PubMed ID: 29112997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Buprenorphine versus methadone in the treatment of pregnant opioid-dependent patients: effects on the neonatal abstinence syndrome.
    Jones HE; Johnson RE; Jasinski DR; O'Grady KE; Chisholm CA; Choo RE; Crocetti M; Dudas R; Harrow C; Huestis MA; Jansson LM; Lantz M; Lester BM; Milio L
    Drug Alcohol Depend; 2005 Jul; 79(1):1-10. PubMed ID: 15943939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Finding the right treatment for neonatal abstinence syndrome: is this the right time?
    Yen E; Davis JM
    J Perinatol; 2018 Jul; 38(7):785-787. PubMed ID: 29515226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological Treatments for Neonatal Abstinence Syndrome: A Systematic Review and Network Meta-analysis.
    Disher T; Gullickson C; Singh B; Cameron C; Boulos L; Beaubien L; Campbell-Yeo M
    JAMA Pediatr; 2019 Mar; 173(3):234-243. PubMed ID: 30667476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Buprenorphine + naloxone in the treatment of opioid dependence during pregnancy-initial patient care and outcome data.
    Debelak K; Morrone WR; O'Grady KE; Jones HE
    Am J Addict; 2013; 22(3):252-4. PubMed ID: 23617867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship of plasma buprenorphine and norbuprenorphine to withdrawal symptoms during dose induction, maintenance and withdrawal from sublingual buprenorphine.
    Kuhlman JJ; Levine B; Johnson RE; Fudala PJ; Cone EJ
    Addiction; 1998 Apr; 93(4):549-59. PubMed ID: 9684393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of buprenorphine in pregnancy: patient management and effects on the neonate.
    Johnson RE; Jones HE; Fischer G
    Drug Alcohol Depend; 2003 May; 70(2 Suppl):S87-101. PubMed ID: 12738353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clonidine as an adjunct therapy to opioids for neonatal abstinence syndrome: a randomized, controlled trial.
    Agthe AG; Kim GR; Mathias KB; Hendrix CW; Chavez-Valdez R; Jansson L; Lewis TR; Yaster M; Gauda EB
    Pediatrics; 2009 May; 123(5):e849-56. PubMed ID: 19398463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Cohort Comparison of Buprenorphine versus Methadone Treatment for Neonatal Abstinence Syndrome.
    Hall ES; Isemann BT; Wexelblatt SL; Meinzen-Derr J; Wiles JR; Harvey S; Akinbi HT
    J Pediatr; 2016 Mar; 170():39-44.e1. PubMed ID: 26703873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of Safety and Efficacy of Methadone vs Morphine for Treatment of Neonatal Abstinence Syndrome: A Randomized Clinical Trial.
    Davis JM; Shenberger J; Terrin N; Breeze JL; Hudak M; Wachman EM; Marro P; Oliveira EL; Harvey-Wilkes K; Czynski A; Engelhardt B; D'Apolito K; Bogen D; Lester B
    JAMA Pediatr; 2018 Aug; 172(8):741-748. PubMed ID: 29913015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.